ClinicalTrials.Veeva

Menu

Free Amino Acid-based Formula to Treat Children Cow's Milk Protein Allergy

E

Edetec Indústria Alimentícia

Status and phase

Completed
Phase 2

Conditions

Cow's Milk Allergy

Treatments

Dietary Supplement: Amix

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT02536482
U1111-1173-4156

Details and patient eligibility

About

It is a study to assess the tolerance to a new commercially available infant formula in children affected by Cow's Milk Allergy.

Full description

In the present study, the children will be followed-up during the treatment with the new formula for Cow's Milk Allergy. They will have monthly doctor's appointment, when the weight, height and symptoms will be evaluated, by a questionnaire and a physical examination.

Enrollment

15 patients

Sex

All

Ages

1 day to 5 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Children with cow's milk allergy

Exclusion criteria

  • Children without cow's milk allergy

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

15 participants in 1 patient group

Amix
Experimental group
Description:
Dietary supplement. The formula is based in free amino-acid to treat children with cow's milk allergy. The children should have a minimum consumption of 400 mL, daily.
Treatment:
Dietary Supplement: Amix

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems